Access and benefit sharing: streamlining legal frameworks for global health equity
In November 2024, the state parties to the Convention on Biological Diversity (CBD) invited pharmaceutical companies utilising publicly available digital sequence information (DSI) from genetic resources to contribute 0.
Authors
- Ayelet Berman (ORCID: https://orcid.org/0009-0008-6681-2438)
- Bart Van Vooren
Institutions
- National University Health System (SG)
- Covington and Burling (US)
Publication Details
- Journal
- BMJ Public Health
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1136/bmjph-2025-002830
- Citations
- 1
- Primary Topic
- Health Systems, Economic Evaluations, Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 3.13